ASTH
Astrana Health, Inc.
$38.62
-3.09%
$2.2B
No data for this timeframe.
Vol
Market Cap$2.2B
Cap SizeMid Cap
Analyst ConsensusStrong Buy (88%)
Inst. Holders50 funds
Inst. Value$535.5M
Inst. Activity10 buys / 7 sells
SEC Reports2
Exchange Nasdaq·Sector Services-Management Consulting Services·Inc. DE·CIK 0001083446·Prev Close $39.85
Recent Activity
Jun 10, 2026
SEC
Astrana Health filed an 8-K reporting the results of its 2026 Annual Meeting of Stockholders, where shareholders approve
8-K — Impact 3/10
Jun 10, 2026
Insider
Dai, Weili was granted 4,525 shares
Director
Jun 10, 2026
Insider
Chiang John was granted 4,525 shares
Director
Jun 10, 2026
Insider
Kitayama Mitchell W was granted 4,991 shares
Director
Apr 17, 2026
SEC
Astrana Health, Inc. has filed a definitive proxy statement for its 2026 annual meeting, proposing the election of nine
DEFA14A — Impact 2/10
Inst.
WELLINGTON MANAGEMENT GROUP LLP — ADD
1,341,824 shares ($32.9M)
Inst.
AMERIPRISE FINANCIAL INC — ADD
551,599 shares ($13.5M)
May 7, 2026
earnings_calendar
ASTH Q1 2026 Earnings Scheduled — 2026-05-07
Price Targets
$46.00
+19.1% upside
Buy
Current $38.62
Low $41.00
Median $45.00
High $50.00
9 analysts
$41.00
$50.00
Analyst Ratings
7Strong Buy
8Buy
2Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Jun 2, 2026 | BTIG | REITERATE | Buy → Buy |
| May 26, 2026 | Barclays | UPGRADE | Equal-Weight → Overweight |
| May 14, 2026 | Truist Securities | MAINTAIN | Buy → Buy |
| May 12, 2026 | TD Cowen | MAINTAIN | Buy → Buy |
| May 11, 2026 | Barclays | MAINTAIN | Equal-Weight → Equal-Weight |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $0.73 ▲ +12.3% | $0.73 — $0.73 | 26% YoY | 2 |
| Next Q | $0.79 ▲ +5.3% | $0.76 — $0.82 | 17% YoY | 2 |
| Current FY | $2.92 ▲ +8.6% | $2.85 — $2.99 | 38% YoY | 2 |
| Next FY | $3.41 ▲ +14.0% | $3.34 — $3.48 | 17% YoY | 2 |
Latest Reports
NEUTRAL
8-K
3/10
Astrana Health filed an 8-K reporting the results of its 2026 Annual Meeting of Stockholders, where shareholders approve
Jun 10, 2026
NEUTRAL
DEFA14A
2/10
Astrana Health, Inc. has filed a definitive proxy statement for its 2026 annual meeting, proposing the election of nine
Apr 17, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| BlackRock, Inc. | $151.1M | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $55.8M | — |
| VANGUARD CAPITAL MANAGEMENT LLC | $41.9M | — |
| STATE STREET CORP | $40.5M | — |
| DIMENSIONAL FUND ADVISORS LP | $33.5M | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 10, 2026 | Dai, Weili | A | $0.00 |
| Jun 10, 2026 | Chiang John | A | $0.00 |
| Jun 10, 2026 | Kitayama Mitchell | A | $0.00 |
| Jun 10, 2026 | Dong Linda | A | $0.00 |
| Jun 10, 2026 | Mazdyasni Matthew | A | $0.00 |
50 institutional holders with $535.5M total value (21,837,241 shares) as of 2026-Q1. Top holders: BlackRock,, VANGUARD, VANGUARD. Net buying activity: 10 institutions added/increased vs 7 reduced.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 6,163,727 | $151.1M | 28.2% | — |
| 2 | VANGUARD PORTFOLIO MANAGEMENT LLC | 2,276,806 | $55.8M | 10.4% | — |
| 3 | VANGUARD CAPITAL MANAGEMENT LLC | 1,710,262 | $41.9M | 7.8% | — |
| 4 | STATE STREET CORP | 1,650,490 | $40.5M | 7.6% | — |
| 5 | DIMENSIONAL FUND ADVISORS LP | 1,368,079 | $33.5M | 6.3% | — |
| 6 | WELLINGTON MANAGEMENT GROUP LLP | 1,341,824 | $32.9M | 6.1% | ADD +81.6% |
| 7 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 644,171 | $15.8M | 2.9% | — |
| 8 | BANK OF AMERICA CORP /DE/ | 574,729 | $14.1M | 2.6% | DOUBLED +193.4% |
| 9 | AMERIPRISE FINANCIAL INC | 551,599 | $13.5M | 2.5% | ADD +25.9% |
| 10 | DIAMOND HILL CAPITAL MANAGEMENT INC | 544,034 | $13.3M | 2.5% | ADD +25.7% |
| 11 | HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | 481,520 | $11.8M | 2.2% | ADD +44.2% |
| 12 | FMR LLC | 416,125 | $10.2M | 1.9% | TRIM -61.1% |
| 13 | ROYCE & ASSOCIATES LP | 396,961 | $9.7M | 1.8% | ADD +34.3% |
| 14 | BNP Paribas Asset Management Holding S.A. | 351,630 | $8.6M | 1.6% | DOUBLED +74124.1% |
| 15 | Invesco Ltd. | 351,112 | $8.6M | 1.6% | ADD +46.0% |
| 16 | MORGAN STANLEY | 338,803 | $8.3M | 1.6% | — |
| 17 | GOLDMAN SACHS GROUP INC | 295,329 | $7.2M | 1.4% | — |
| 18 | VANGUARD FIDUCIARY TRUST CO | 293,003 | $7.2M | 1.3% | — |
| 19 | EARNEST PARTNERS LLC | 219,995 | $5.4M | 1.0% | — |
| 20 | PUBLIC SECTOR PENSION INVESTMENT BOARD | 154,298 | $3.8M | 0.7% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP | ADD | 738,853 | 1,341,824 | +81.6% | $32.9M | 2026-Q1 |
| AMERIPRISE FINANCIAL INC | ADD | 437,996 | 551,599 | +25.9% | $13.5M | 2026-Q1 |
| DIAMOND HILL CAPITAL MANAGEMENT INC | ADD | 432,726 | 544,034 | +25.7% | $13.3M | 2026-Q1 |
| FMR LLC | TRIM | 1,069,809 | 416,125 | -61.1% | $10.2M | 2026-Q1 |
| SEI INVESTMENTS CO | ADD | 69,390 | 134,899 | +94.4% | $3.3M | 2026-Q1 |
| BALYASNY ASSET MANAGEMENT L.P. | TRIM | 114,009 | 58,448 | -48.7% | $1.4M | 2026-Q1 |
| BLAIR WILLIAM & CO/IL | TRIM | 42,901 | 31,870 | -25.7% | $781.5K | 2026-Q1 |
| State of Tennessee, Department of Treasury | ADD | 16,484 | 24,784 | +50.4% | $607.7K | 2026-Q1 |
| FRANKLIN RESOURCES INC | TRIM | 35,241 | 24,073 | -31.7% | $590.3K | 2026-Q1 |
| ExodusPoint Capital Management, LP | NEAR_EXIT | 99,964 | 19,151 | -80.8% | $469.6K | 2026-Q1 |
| Envestnet Portfolio Solutions, Inc. | ADD | 10,852 | 15,973 | +47.2% | $391.7K | 2026-Q1 |
| FIFTH THIRD BANCORP | DOUBLED | 251 | 12,438 | +4855.4% | $305.0K | 2026-Q1 |
| Rockefeller Capital Management L.P. | ADD | 2,808 | 3,674 | +30.8% | $90.1K | 2026-Q1 |
| NISA INVESTMENT ADVISORS, LLC | DOUBLED | 489 | 1,322 | +170.3% | $32.4K | 2026-Q1 |
| STRS OHIO | TRIM | 1,600 | 500 | -68.7% | $12.3K | 2026-Q1 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | NEAR_EXIT | 9,208 | 202 | -97.8% | $5.0K | 2026-Q1 |
| CWM, LLC | ADD | 98 | 129 | +31.6% | $3.2K | 2026-Q1 |
| WELLINGTON MANAGEMENT GROUP LLP | DOUBLED | 142,560 | 738,853 | +418.3% | $18.3M | 2025-Q4 |
| BANK OF AMERICA CORP /DE/ | DOUBLED | 172,855 | 507,101 | +193.4% | $12.6M | 2025-Q4 |
| Invesco Ltd. | ADD | 243,236 | 355,216 | +46.0% | $8.8M | 2025-Q4 |
| ROYCE & ASSOCIATES LP | ADD | 259,353 | 348,331 | +34.3% | $8.6M | 2025-Q4 |
| ENVESTNET ASSET MANAGEMENT INC | DOUBLED | 7,602 | 126,279 | +1561.1% | $3.1M | 2025-Q4 |
| WELLS FARGO & COMPANY/MN | ADD | 58,177 | 116,311 | +99.9% | $2.9M | 2025-Q4 |
| SEI INVESTMENTS CO | DOUBLED | 16,667 | 69,390 | +316.3% | $1.7M | 2025-Q4 |
| FIRST TRUST ADVISORS LP | TRIM | 52,139 | 25,789 | -50.5% | $639.8K | 2025-Q4 |
12 unique insiders with 19 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 10, 2026 | Dai, Weili | Director | AWARD | 4,525 | — | — |
| Jun 10, 2026 | Chiang John | Director | AWARD | 4,525 | — | — |
| Jun 10, 2026 | Kitayama Mitchell W | Director | AWARD | 4,991 | — | — |
| Jun 10, 2026 | Dong Linda | Director | AWARD | 4,525 | — | — |
| Jun 10, 2026 | Mazdyasni Matthew | Director | AWARD | 4,525 | — | — |
| Jun 10, 2026 | Schmidt David | Director | AWARD | 4,525 | — | — |
| May 16, 2026 | Basho Chandan | COO and CFO | TAX W/H | 8,155 | $38.26 | $312.0K |
| Apr 14, 2026 | Basho Chandan | COO and CFO | TAX W/H | 3,870 | $29.07 | $112.5K |
| Apr 6, 2026 | Lam Thomas S. | Director | AWARD | 41,667 | — | — |
| Apr 6, 2026 | Sim Kenneth T. | Executive Chairman | AWARD | 100,000 | — | — |
| Apr 6, 2026 | Sim Brandon | CEO and President | AWARD | 201,056 | — | — |
| Apr 2, 2026 | Basho Chandan | COO and CFO | TAX W/H | 2,092 | $25.05 | $52.4K |
| Apr 1, 2026 | Kumar Dinesh M. | Chief Medical Officer | TAX W/H | 57,980 | $24.51 | $1.4M |
| Apr 1, 2026 | Kumar Dinesh M. | Chief Medical Officer | AWARD | 35,300 | — | — |
| Mar 26, 2026 | Sobotka Glenn | Chief Accounting Officer | TAX W/H | 662 | $24.27 | $16.1K |
| Mar 5, 2026 | Kumar Dinesh M. | Chief Medical Officer | TAX W/H | 1,697 | $25.07 | $42.5K |
| Mar 5, 2026 | Lam Thomas S. | Director | TAX W/H | 9,266 | $25.07 | $232.3K |
| Mar 5, 2026 | Basho Chandan | COO and CFO | TAX W/H | 1,240 | $25.07 | $31.1K |
| Feb 2, 2026 | Sim Brandon | CEO and President | EXERCISE | 21,334 | $23.24 | $495.8K |
2 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 2 neutral. Avg impact: 2.5/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Current analyst consensus: Strong Buy (88% buy). Based on 17 analysts: 7 strong buy, 8 buy, 2 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$46.00 mean target
+19.1% upside
Buy (1.36)
$41.00 Low
$50.00 High
| Metric | Value |
|---|---|
| Current Price | $38.62 |
| Target Low | $41.00 |
| Target Mean | $46.00 |
| Target Median | $45.00 |
| Target High | $50.00 |
| # Analysts | 9 |
| Recommendation | Buy (1.36) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$0.73 | $0.73 | $0.73 | 25.9% | +12.3% | 1↑ 0↓ | $1.0B | 50.5% | 2 |
| Next Q 2026-09-30 |
$0.79 | $0.76 | $0.82 | 17.0% | +5.3% | 1↑ 0↓ | $1.0B | 7.2% | 2 |
| Current FY 2026-12-31 |
$2.92 | $2.85 | $2.99 | 37.6% | +8.6% | 1↑ 0↓ | $4.0B | 25.8% | 2 |
| Next FY 2027-12-31 |
$3.41 | $3.34 | $3.48 | 16.8% | +14.0% | 1↑ 0↓ | $4.4B | 9.3% | 2 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $0.730 | |
| 7d ago | $0.650 | +0.080 |
| 30d ago | $0.650 | +0.080 |
| 60d ago | $0.000 | +0.730 |
| 90d ago | $0.000 | +0.730 |
6 analyst firms have rated this stock: 1 upgrades, 0 downgrades, 0 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Jun 2, 2026 | BTIG | REITERATE | Buy | Buy |
| May 26, 2026 | Barclays | UPGRADE | Equal-Weight | Overweight |
| May 14, 2026 | Truist Securities | MAINTAIN | Buy | Buy |
| May 12, 2026 | TD Cowen | MAINTAIN | Buy | Buy |
| May 11, 2026 | Barclays | MAINTAIN | Equal-Weight | Equal-Weight |
| May 8, 2026 | BTIG | MAINTAIN | Buy | Buy |
| May 8, 2026 | Needham | MAINTAIN | Buy | Buy |
| Apr 15, 2026 | Baird | MAINTAIN | Outperform | Outperform |
| Mar 13, 2026 | Truist Securities | MAINTAIN | Buy | Buy |
| Feb 2, 2026 | BTIG | MAINTAIN | Buy | Buy |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 7 | 8 | 2 | 0 | 0 | 88% | |
| May 1, 2026 | 7 | 7 | 3 | 0 | 0 | 82% | |
| Apr 1, 2026 | 7 | 7 | 3 | 0 | 0 | 82% | |
| Mar 1, 2026 | 7 | 7 | 3 | 0 | 0 | 82% | |
| Feb 1, 2026 | 7 | 7 | 3 | 0 | 0 | 82% | |
| Jan 1, 2026 | 7 | 7 | 3 | 0 | 0 | 82% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 7, 2026
earnings_calendar
ASTH Q1 2026 Earnings Scheduled — 2026-05-07
Mar 3, 2026
short_interest
FTD: ASTH — 151,929 shares ($4.0M) failed to deliver
Settlement: 20260303, Price: $26.32, FTD Value: $3,998,771.28, ASTRANA HEALTH INC. COMMON STO
Mar 2, 2026
earnings_calendar
ASTH Q4 2025 Earnings After Market Close — 2026-03-02